- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-06-0030473

Axa Life Sciences Private Limited
About Axa Life Sciences Private Limited
Data last updated:
Axa Life Sciences Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U36912AP2014PTC095356. Its GSTIN is 37AANCA0788R1ZQ (Andhra Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹18.5 Lakh. It is led by directors Sirisha Talluri and Anvesh Garidepalli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at #32 – 20 – 3/1A Gummadithota Area Mogalrajpuram, Vijayawada, Andhra Pradesh, India – 520010.
As per the financials filed for FY 2023, the company reported a revenue of ₹92.07 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.52 Lakh (net margin 2.7%) and EBITDA of ₹3.92 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹5.84 Lakh on record.
Axa Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-06-0030473). The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Axa Life Sciences
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address#32 – 20 – 3/1A Gummadithota Area Mogalrajpuram, Vijayawada, Andhra Pradesh, India – 520010
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Axa Life Sciences Private Limited FY 2024 filings available
Axa Life Sciences Private Limited reported revenue of ₹92.07 Lakh (up 10% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Axa Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 10% growth in the latest year. EBITDA fell 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axa Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹92.07 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.92 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.52 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axa Life Sciences Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axa Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Axa Life Sciences Private Limited
Axa Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirisha Talluri | Director | 19 Sep 2014 | 12 Years 1 Months | Current |
| Anvesh Garidepalli | Director | 19 Sep 2014 | 12 Years 1 Months | Current |
Auditor Details of Axa Life Sciences Private Limited
Axa Life Sciences Private Limited is audited by YOGESWARA AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| YOGESWARA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Axa Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axa Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2023 | Hdfc Bank Limited | ₹5.84 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Axa Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Axa Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axa Life Sciences Private Limited
Axa Life Sciences Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Vemulapalli Srikanth ceased to be Director on 04 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Axa Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axa Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axa Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axa Life Sciences Private Limited
Axa Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AANCA0788R1ZQ | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axa Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axa Life Sciences Private Limited
Axa Life Sciences is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 September 2014 (12+ years old) and is registered under CIN U36912AP2014PTC095356.
Axa Life Sciences reported revenue of ₹92.07 Lakh for FY 2023 (up 10% YoY).
Axa Life Sciences has 2 current directors:
- Sirisha Talluri - Director
- Anvesh Garidepalli - Director
Axa Life Sciences reported a net profit of ₹2.52 Lakh (net margin 2.7%) and EBITDA of ₹3.92 Lakh (EBITDA margin 4.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Axa Life Sciences is 2% over three years and 8% over five years. In the latest year (FY 2023) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Axa Life Sciences is 37AANCA0788R1ZQ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Axa Life Sciences is U36912AP2014PTC095356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axa Life Sciences was incorporated on 19 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Vijayawada.
Vemulapalli Srikanth ceased to be Director on 04 Oct 2021. Aruapalli Naga Subramanyam ceased to be Director on 19 Feb 2019. Kranthi Kumar Rajapatruni ceased to be Director on 22 Feb 2018. Axa Life Sciences has 5 board changes on record in total.
Yes, Axa Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-06-0030473).